Global Director, Health Economics And Outcomes Research, Oncology
CurrentAs a Global Director, Health Economics and Outcomes Research (HEOR) in Oncology at Ipsen, I am responsible for leading HEOR input and strategy development to support optimal pricing / reimbursement and patient access throughout product lifecycles.I lead, plan and execute payer-focused evidence that addresses payer needs and demonstrates product value – including HEOR aspects of clinical trials, prospective / retrospective real-world studies, and economic modelling. This requires close collaboration with internal stakeholders including market access, clinical development and medical affairs, as well as external suppliers, data sources and subject matter experts / thought leaders.Ipsen is an agile mid-size biopharmaceutical company, where the Global HEOR team closely collaborates with affiliates to plan and deliver HTA / reimbursement submissions and negotiations, as well as to maintain or expand reimbursement and increase product uptake through provision of value tools.As a senior member of the team, I am a subject matter expert, helping to develop the HEOR group, and to expand and evolve Ipsen’s capabilities and external relationships. Additionally, helping to identify and plan for future trends, challenges and opportunities in HEOR / market access (e.g. ways of working, technical skills, policy changes).